<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35528001</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">1664-2392</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>13</Volume>
            <PubDate>
              <Year>2022</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in endocrinology</Title>
          <ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Growth Hormone Is Beneficial for Induction of Spermatogenesis in Adult Patients With Congenital Combined Pituitary Hormone Deficiency.</ArticleTitle>
        <Pagination>
          <StartPage>868047</StartPage>
          <MedlinePgn>868047</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">868047</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2022.868047</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Gonadotropins are effective in inducing spermatogenesis in patients with congenital combined pituitary hormone deficiency (CCPHD). Data on recombinant human growth hormone(rhGH) adjuvant treatment to improve gonadotropin-induced spermatogenesis are limited.</AbstractText>
          <AbstractText Label="DESIGN AND SETTING" NlmCategory="UNASSIGNED">This retrospective study included 60 male patients with CCPHD on a relatively large case series in a single center from mainland China. Twenty-nine patients who received gonadotropin therapy alone were defined as the Gn group, while 31 patients treated with a combination of rhGH and gonadotropins were defined as GH/Gn group.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Spermatogenesis rate was 96.77% (30/31) and 62.07% (18/29) in the GH/Gn and Gn group, respectively (P &lt; 0.001). The time for initial sperm appearance in the GH/Gn group was shorter than in the Gn group (14 versus 23 months, P &lt; 0.001). A higher level of serum testosterone was achieved in the GH/Gn group than in the Gn group (4.79 versus 3.38 ng/mL, P = 0.026). After adjustment for potential confounders, rhGH supplementation was an independent beneficial factor on spermatogenesis (HR = 2.294, 95% CI: 1.143-4.604, P = 0.019).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">rhGH induces earlier spermatogenesis in patients with CCPHD, which encourages the co-treatment with rhGH and gonadotropins in CCPHD patients.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Zhu, Nie, Wang, Huang, Yu, Zhang, Zhang, Sun, Mao and Wu.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Yiyi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>National Health Commission (NHC) Key Laboratory of Endocrinology, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nie</LastName>
            <ForeName>Min</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>National Health Commission (NHC) Key Laboratory of Endocrinology, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xi</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>National Health Commission (NHC) Key Laboratory of Endocrinology, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Qibin</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>National Health Commission (NHC) Key Laboratory of Endocrinology, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Bingqing</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>National Health Commission (NHC) Key Laboratory of Endocrinology, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Rui</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>National Health Commission (NHC) Key Laboratory of Endocrinology, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Junyi</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>National Health Commission (NHC) Key Laboratory of Endocrinology, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Bang</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>National Health Commission (NHC) Key Laboratory of Endocrinology, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mao</LastName>
            <ForeName>Jiangfeng</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>National Health Commission (NHC) Key Laboratory of Endocrinology, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Xueyan</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>National Health Commission (NHC) Key Laboratory of Endocrinology, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Endocrinol (Lausanne)</MedlineTA>
        <NlmUniqueID>101555782</NlmUniqueID>
        <ISSNLinking>1664-2392</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D006062">Gonadotropins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>12629-01-5</RegistryNumber>
          <NameOfSubstance UI="D019382">Human Growth Hormone</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>3XMK78S47O</RegistryNumber>
          <NameOfSubstance UI="D013739">Testosterone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C580003">Combined Pituitary Hormone Deficiency</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006062" MajorTopicYN="N">Gonadotropins</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019382" MajorTopicYN="Y">Human Growth Hormone</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007018" MajorTopicYN="Y">Hypopituitarism</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013091" MajorTopicYN="Y">Spermatogenesis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013739" MajorTopicYN="N">Testosterone</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">congenital combined pituitary hormone deficiency</Keyword>
        <Keyword MajorTopicYN="N">gonadotropin</Keyword>
        <Keyword MajorTopicYN="N">insulin-like growth factor 1</Keyword>
        <Keyword MajorTopicYN="N">recombinant human growth hormone</Keyword>
        <Keyword MajorTopicYN="N">spermatogenesis</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>9</Day>
          <Hour>3</Hour>
          <Minute>49</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35528001</ArticleId>
        <ArticleId IdType="pmc">PMC9074387</ArticleId>
        <ArticleId IdType="doi">10.3389/fendo.2022.868047</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Vergier J, Castinetti F, Saveanu A, Girard N, Brue T, Reynaud R. DIAGNOSIS OF ENDOCRINE DISEASE: Pituitary Stalk Interruption Syndrome: Etiology and Clinical Manifestations. Eur J Endocrinol (2019) 181(5):R199–209. doi: 10.1530/EJE-19-0168
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/EJE-19-0168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Guo Q, Yang Y, Mu Y, Lu J, Pan C, Dou J, et al. . Pituitary Stalk Interruption Syndrome in Chinese People: Clinical Characteristic Analysis of 55 Cases. PloS One (2013) 8(1):e53579. doi: 10.1371/journal.pone.0053579
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0053579</ArticleId>
            <ArticleId IdType="pmc">PMC3544917</ArticleId>
            <ArticleId IdType="pubmed">23341953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mao J, Xu H, Wang X, Huang B, Liu Z, Zhen J, et al. . Congenital Combined Pituitary Hormone Deficiency Patients Have Better Responses to Gonadotrophin-Induced Spermatogenesis Than Idiopathic Hypogonadotropic Hypogonadism Patients. Hum Reprod (2015) 30(9):2031–7. doi: 10.1093/humrep/dev158
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/humrep/dev158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gasco V, Caputo M, Lanfranco F, Ghigo E, Grottoli S. Management of GH Treatment in Adult GH Deficiency. Best Pract Res Clin Endocrinol Metab (2017) 31(1):13–24. doi: 10.1016/j.beem.2017.03.001
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.beem.2017.03.001</ArticleId>
            <ArticleId IdType="pubmed">28477728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zalel Y, Draysen E, Goldschmit R, Zadik Z, Shoham Z. A Prospective Pilot Study of Co-Treatment With Growth Hormone and Gonadotropins for Improving Spermatogenesis in Normogonadotropic Patients With Severe Oligoteratoasthenospermia. Gynecol Endocrinol (1996) 10(1):23–8. doi: 10.3109/09513599609041266
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/09513599609041266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Giagulli VA. Absence of Effect of Recombinant Growth Hormone to Classic Gonadotropin Treatment on Spermatogenesis of Patients With Severe Hypogonadotropic Hypogonadism. Arch Androl (1999) 43(1):47–53. doi: 10.1080/014850199262724
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/014850199262724</ArticleId>
            <ArticleId IdType="pubmed">10445104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Carani C, Granata AR, De Rosa M, Garau C, Zarrilli S, Paesano L, et al. . The Effect of Chronic Treatment With GH on Gonadal Function in Men With Isolated GH Deficiency. Eur J Endocrinol (1999) 140(3):224–30. doi: 10.1530/eje.0.1400224
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/eje.0.1400224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chandrashekar V, Zaczek D, Bartke A. The Consequences of Altered Somatotropic System on Reproduction. Biol Reprod (2004) 71(1):17–27. doi: 10.1095/biolreprod.103.027060
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1095/biolreprod.103.027060</ArticleId>
            <ArticleId IdType="pubmed">15028633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Dosouto C, Calaf J, Polo A, Haahr T, Humaidan P. Growth Hormone and Reproduction: Lessons Learned From Animal Models and Clinical Trials. Front Endocrinol (Lausanne) (2019) 10:404. doi: 10.3389/fendo.2019.00404
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fendo.2019.00404</ArticleId>
            <ArticleId IdType="pmc">PMC6607366</ArticleId>
            <ArticleId IdType="pubmed">31297089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Baker J, Hardy MP, Zhou J, Bondy C, Lupu F, Bellvé AR, et al. . Effects of an Igf1 Gene Null Mutation on Mouse Reproduction. Mol Endocrinol (1996) 10(9):903–18. doi: 10.1210/mend.10.7.8813730
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/mend.10.7.8813730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Matsushima M, Kuroda K, Shirai M, Ando K, Sugisaki T, Noguchi T. Spermatogenesis in Snell Dwarf Little and Congenitally Hypothyroid Mice. Int J Androl (1986) 9(2):132–40. doi: 10.1111/j.1365-2605.1986.tb00876.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2605.1986.tb00876.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chandrashekar V, Bartke A. Induction of Endogenous Insulin-Like Growth Factor-I Secretion Alters the Hypothalamic-Pituitary-Testicular Function in Growth Hormone-Deficient Adult Dwarf Mice. Biol Reprod (1993) 48(3):544–51. doi: 10.1095/biolreprod48.3.544
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1095/biolreprod48.3.544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Castinetti F, Reynaud R, Quentien MH, Jullien N, Marquant E, Rochette C, et al. . Combined Pituitary Hormone Deficiency: Current and Future Status. J Endocrinol Invest (2015) 38(1):1–12. doi: 10.1007/s40618-014-0141-2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40618-014-0141-2</ArticleId>
            <ArticleId IdType="pubmed">25200994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yuen KCJ, Biller BMK, Radovick S, Carmichael JD, Jasim S, Pantalone KM, et al. . American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Growth Hormone Deficiency in Adults and Patients Transitioning From Pediatric to Adult Care. Endocr Pract (2019) 25(11):1191–232. doi: 10.4158/GL-2019-0405
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4158/GL-2019-0405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, et al. . Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2016) 101(11):3888–921. doi: 10.1210/jc.2016-2118
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2016-2118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ma W, Mao J, Nie M, Wang X, Zheng J, Liu Z, et al. . Gonadotropin Therapy Once a Week for Spermatogenesis in Hypogonadotropic Hypogonadism. Endocr Pract (2021) 27(11):1119–27. doi: 10.1016/j.eprac.2021.04.009
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.eprac.2021.04.009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bidlingmaier M, Friedrich N, Emeny RT, Spranger J, Wolthers OD, Roswall J, et al. . Reference Intervals for Insulin-Like Growth Factor-1 (Igf-I) From Birth to Senescence: Results From a Multicenter Study Using a New Automated Chemiluminescence IGF-I Immunoassay Conforming to Recent International Recommendations. J Clin Endocrinol Metab (2014) 99(5):1712–21. doi: 10.1210/jc.2013-3059
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2013-3059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cooper TG, Noonan E, Von Eckardstein S, Auger J, Baker HW, Behre HM, et al. . World Health Organization Reference Values for Human Semen Characteristics. Hum Reprod Update (2010) 16(3):231–45. doi: 10.1093/humupd/dmp048
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/humupd/dmp048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cannarella R, Crafa A, La Vignera S, Condorelli RA, Calogero AE. Role of the GH-IGF1 Axis on the Hypothalamus-Pituitary-Testicular Axis Function: Lessons From Laron Syndrome. Endocr Connect (2021) 10(9):1006–17. doi: 10.1530/EC-21-0252
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/EC-21-0252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tenuta M, Carlomagno F, Cangiano B, Kanakis G, Pozza C, Sbardella E, et al. . Somatotropic-Testicular Axis: A Crosstalk Between GH/IGF-I and Gonadal Hormones During Development, Transition, and Adult Age. Andrology (2021) 9(1):168–84. doi: 10.1111/andr.12918
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/andr.12918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Macdonald AA, Herbison GP, Showell M, Farquhar CM. The Impact of Body Mass Index on Semen Parameters and Reproductive Hormones in Human Males: A Systematic Review With Meta-Analysis. Hum Reprod Update (2010) 16(3):293–311. doi: 10.1093/humupd/dmp047
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/humupd/dmp047</ArticleId>
            <ArticleId IdType="pubmed">19889752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rastrelli G, Corona G, Mannucci E, Maggi M. Factors Affecting Spermatogenesis Upon Gonadotropin-Replacement Therapy: A Meta-Analytic Study. Andrology (2014) 2(6):794–808. doi: 10.1111/andr.262
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/andr.262</ArticleId>
            <ArticleId IdType="pubmed">25271205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wen J, Jiangfeng M, Min N, Xi W, Shuying L, Bingqing Y, et al. . Desmopressin Suppresses Gonadotropin-Induced Spermatogenesis in Patients With Pituitary Stalk Interruption Syndrome: A Retrospective, Single-Center Cohort Study. Endocr Pract (2021) 27(2):124–30. doi: 10.1016/j.eprac.2020.08.001
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.eprac.2020.08.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Liu Z, Mao J, Wu X, Xu H, Wang X, Huang B, et al. . Efficacy and Outcome Predictors of Gonadotropin Treatment for Male Congenital Hypogonadotropic Hypogonadism: A Retrospective Study of 223 Patients. Med (Baltimore) (2016) 95(9):e2867. doi: 10.1097/MD.0000000000002867
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000002867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kulin HE, Samojlik E, Santen R, Santner S. The Effect of Growth Hormone on the Leydig Cell Response to Chorionic Gonadotrophin in Boys With Hypopituitarism. Clin Endocrinol (Oxf) (1981) 15(5):463–72. doi: 10.1111/j.1365-2265.1981.tb00689.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2265.1981.tb00689.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Balducci R, Toscano V, Mangiantini A, Bianchi P, Guglielmi R, Boscherini B. The Effect of Growth Hormone Administration on Testicular Response During Gonadotropin Therapy in Subjects With Combined Gonadotropin and Growth Hormone Deficiencies. Acta Endocrinol (Copenh) (1993) 128(1):19–23. doi: 10.1530/acta.0.1280019
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/acta.0.1280019</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
